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http://dx.doi.org/10.1016/j.stem.2013.04.025Transcription factors (TFs) and their
networks are central effectors controlling
pluripotency (Young, 2011). Numerous
involved TFs have been identified, but a
subset of core pluripotency TFs regulates
the majority of others. One such factor,
Nanog, is expressed in pluripotent cells,
is required for self-renewal of mouse em-
bryonic stem cells (ESCs) in vitro, is able
to force ESC self-renewal upon overex-
pression in the absence of LIF, and is
necessary for the normal development of
early mouse embryos (reviewed in Young,
2011). Several studies have shown that
Nanog expression is heterogeneous in
populations of pluripotent ESCs, which
can express high or low Nanog levels
(reviewed in Young, 2011), making
Nanog regulation an interesting model for
analyzing the dynamic regulation of fluctu-
ating but stable TF expression states.
Recently, allele-specific expression of
Nanog—as assessed by a combination
of fluorescent in situ hybridization (FISH)
to detectNanogmRNAandprotein-based
assays involving fusion of destabilized
fluorescent proteins connected to Nanog
via a self-cleavable peptide—has been
described as a potential mechanism for
regulation of Nanog expression and,
consequently, pluripotency (Miyanari and
Torres-Padilla, 2012). These studies
suggested that Nanog is predominantly
expressed in a monoallelic manner in
serum/LIF-cultured ESCs but biallelically
in 2i ‘‘ground state’’ conditions, and they
led to the conclusion that switching to
higher biallelic Nanog expression is asso-
ciatedwith amore stable pluripotent state.
However, the underlying mechanisms and
functional relevance remained unclear.
To examine the allelic distribution of
Nanog expression at the protein level,12 Cell Stem Cell 13, July 3, 2013 ª2013 Elsewe created knockin ESC lines in which
the two endogenous Nanog alleles are
targeted with a yellow (VENUS) and red
(KATUSHKA) fluorescent protein (FP),
respectively (Figures S1A and S1B
available online). The FPs are fused
to the C terminus of the Nanog protein,
so they reflect all of the regula-
tory mechanisms influencing the amount
of Nanog protein in ESCs and measure
functionally relevant levels of Nanog
protein, not separate markers that
could have different stability or regula-
tion. To confirm the functionality of the
Nanog-FP fusions, the pluripotency of
the NanogVENUS/KATUSHKA ESC reporter
lines was tested in vitro and in vivo. Loss
of Nanog leads to differentiation and
loss of ESC maintenance, and Nanog-
deficient embryos do not develop past
the implantation stage (Mitsui et al.,
2003). In contrast, NanogVENUS/KATUSHKA
ESCs survived and proliferated normally
over at least 250 population doublings
in vitro, exhibited normal morphology
of undifferentiated ESCs (Figure S1C),
and expressed other ESC-pluripotency-
specific TFs like Oct3/4, Sox2 (Fig-
ure S1D), and Rex1 (data not shown).
Both Nanog-FP reporters also showed
normal downregulation during induced
ESC differentiation upon LIF withdrawal
(Figure S1H). We also verified the
functionality of the NanogVENUS and
NanogKATUSHKA fusion proteins through a
tetraploid aggregation assay, the most
stringent test for ESC pluripotency:
normal day 9.5 embryos can be gener-
ated from NanogVENUS/KATUSHKA ESCs
without contribution of tetraploid cells
(Figure S1E). In addition, the stability of
NanogVENUS and NanogKATUSHKA fusion
proteins is identical to that of wild-vier Inc.type Nanog protein (Figure S1F). Thus,
the normal function and stability of
NanogVENUS and NanogKATUSHKA fusion
proteins indicates that they can be used
as faithful reporters of Nanog protein
expression.
We used the labeled cells to examine
Nanog expression. As previously des-
cribed (Chambers et al., 2007), we saw a
range of Nanog expression levels when
the ESCs were cultured in serum/LIF
conditions, although the dynamic range
was not as broad as in some previous
reports. We found that the extent of this
variability of Nanog expression depended
on culture conditions and strain back-
ground and could also vary between
genetically identical ESC clones. How-
ever, we unexpectedly did not see
evidence for widespreadmonoallelic exp-
ression of Nanog protein (Figure S1G).
Instead, Nanog expression was highly
correlated between the two alleles in
terms of the expression level within
individual cells. This situation remained
unchanged in ESCs cultured over many
weeks (data not shown). Consistent
with prior reports, Nanog expression
changed to a more uniform high distribu-
tion in ESC populations cultured in 3i
ground state conditions (Ying et al.,
2008) (Figure S1G). We cannot exclude
potential monoallelic Nanog protein
expression in a very small subset (less
than 2%) of ESCs due to potential noise
levels of FACS analysis (individual dots
in FACS plots of Figure S1G). We can,
however, conclude that we do not
see evidence for significant monoallelic
Nanog expression in ESCs at the protein
level. Although we did not analyze the
potential for monoallelic Nanog protein
expression in other ESC lines, the normal
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of our cells suggest that monoallelic regu-
lation of expression is not required for
wild-type Nanog function.
It is unclear at this point what the basis
is for the difference between our results
and those of Miyanari and Torres-Padilla
(2012). One possible explanation could
lie with transcriptional bursts, which
seem to occur at a low frequency even
for actively expressed genes (Suter
et al., 2011). Thus, FISH data from one
point in time might detect transcription
of only one allele because of burst
behavior rather than overall monoallelic
Nanog expression. Differences in terms
of stability between the separate reporter
proteins and Nanog itself could also
influence the results seen at the protein
level.
It is important to note that we did not
analyze the potential for allele-specific
bias of Nanog transcription. However,
even if it occurs, our data suggest that it
would not lead to prevalence of Nanog
protein from one allele in ESCs, and thus
it is not likely to be functionally relevant
as a central mechanism of regulating
pluripotency or heterogeneity in pluripo-
tency TF expression. Instead, we wouldsuggest that other regulatory mecha-
nisms, including Nanog autorepression
(Fidalgo et al., 2012, Navarro et al.,
2012) and the topology of the pluripo-
tency TF and signaling networks (MacAr-
thur et al., 2012), underlie the heteroge-
neous molecular states seen in individual
pluripotent cells. A related paper in this
issue from Faddah et al. (2013) draws
similar conclusions to ours regarding bial-
lelic expression of Nanog, and in addition
looks more broadly at variability in Nanog
expression at the transcriptional level and
the activity of a range of reporter con-
structs. Together, these studies will help
inform future analysis of the regulation
of Nanog expression and pluripotency
networks.
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